- Home
- KNDI vs RVPH Comparison
KNDI vs RVPH Comparison
Compare KNDI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- RVPH
- Stock Information
- Founded
- KNDI 2002
- RVPH 2006
- Country
- KNDI China
- RVPH United States
- Employees
- KNDI N/A
- RVPH N/A
- Industry
- KNDI Auto Manufacturing
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- KNDI Consumer Discretionary
- RVPH Health Care
- Exchange
- KNDI Nasdaq
- RVPH Nasdaq
- Market Cap
- KNDI 96.3M
- RVPH 32.8M
- IPO Year
- KNDI N/A
- RVPH N/A
- Fundamental
- Price
- KNDI $1.13
- RVPH $0.36
- Analyst Decision
- KNDI
- RVPH Strong Buy
- Analyst Count
- KNDI 0
- RVPH 5
- Target Price
- KNDI N/A
- RVPH $9.00
- AVG Volume (30 Days)
- KNDI 97.2K
- RVPH 2.6M
- Earning Date
- KNDI 08-15-2025
- RVPH 08-13-2025
- Dividend Yield
- KNDI N/A
- RVPH N/A
- EPS Growth
- KNDI N/A
- RVPH N/A
- EPS
- KNDI N/A
- RVPH N/A
- Revenue
- KNDI $127,569,613.00
- RVPH N/A
- Revenue This Year
- KNDI N/A
- RVPH N/A
- Revenue Next Year
- KNDI N/A
- RVPH N/A
- P/E Ratio
- KNDI N/A
- RVPH N/A
- Revenue Growth
- KNDI 3.21
- RVPH N/A
- 52 Week Low
- KNDI $0.89
- RVPH $0.30
- 52 Week High
- KNDI $2.12
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- KNDI 48.38
- RVPH 31.07
- Support Level
- KNDI $1.06
- RVPH $0.35
- Resistance Level
- KNDI $1.16
- RVPH $0.40
- Average True Range (ATR)
- KNDI 0.07
- RVPH 0.07
- MACD
- KNDI 0.00
- RVPH -0.03
- Stochastic Oscillator
- KNDI 42.86
- RVPH 15.15
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.